Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-23

Clinical Trial Update: Prevention of Seasonal Affective Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating prevention of Seasonal Affective Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GlaxoSmithKline | Conditions: Seasonal Affective Disorder | Phase 3 | Status: COMPLETED